Search

everythinglearnresearchcommunity

for

Search:↓

Dermatologists are hesitant to prescribe Janus kinase inhibitors for alopecia areata due to safety concerns and lack of knowledge.

Dexamethasone oral mini-pulse therapy effectively treats severe alopecia areata when JAK inhibitors can't be used.

Dermatopathia pigmentosa reticularis causes skin discoloration, hair loss, and nail problems.

A child's hair loss after Kawasaki disease may help understand the disease's autoimmune causes.

Mice with a mutated Dsg3 gene showed severe symptoms but not the typical blistering of pemphigus vulgaris.

Effective treatment improved skin and overall symptoms in a lupus patient.

The analyses helped identify different skin diseases in the two dogs.

Thalidomide improved lupus symptoms but caused nerve damage in some patients.

Removing certain brain receptors in mice worsens seizure severity and response to treatment during hormone withdrawal.

Vitamin D Dependent Rickets Type-2A can cause complete hair loss and bone growth issues in infants.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

An extract from Quercus acutissima bark was found to reduce sebum production and block an enzyme linked to acne.

A benign skin tumor grew quickly in a dialysis patient and was surgically removed.

Keratinocyte adhesion problems can cause skin and hair disorders.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Valproic acid is effective for various seizures, but may cause temporary side effects like drowsiness and stomach issues.

A woman with lupus also developed a severe skin condition linked to a genetic factor.

Spontaneous keloids may be linked to nephrogenic systemic fibrosis in dialysis patients.

New mouse models of Pemphigus show severe symptoms and need better treatments.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

Rumex japonicus Houtt. may be an effective treatment for atopic dermatitis by reducing inflammation.

CYLD deficiency in skin tumors disrupts hair follicle cell processes and protein secretion.

The document concludes that detailed clinical descriptions of seven family cases help understand dominant dystrophic epidermolysis bullosa's symptoms and inheritance.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.

Keratosis pilaris significantly affects quality of life and shows specific skin changes.